Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

The Quick Take
Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call today at 2:00...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
FOX NEWS MEDIA'S MULTIPLATFORM COVERAGE OF 2026 MIDTERM ELECTIONS DOMINATES CABLE NEWS DELIVERING NEARLY 4.7 MILLION VIEWERS
'FOX News Democracy 26' Tops CBS News, CNN, MS NOW in Primetime, with 'Evening News' Delivering Lowest Rated Midterm Coverage of the 21st Century FOX News…
Business
Pangaea earnings beat by $0.22, revenue topped estimates
Business
Analysis-Japanese savers have rediscovered interest rates and banks are feeling it
Business
